Abiopharma

MicroAlgo Inc. Develops Quantum Encryption Technology Based on Lattice Cryptography, Integrating into LSQb Algorithms Process of Information Hiding and Transmission to Achieve Anti-Quantum Attack Strategies Enhancement

Change in holdings of interested parties/officers - Periodic report amendment

H.B. Fuller Advances Sustainable Packaging, Enhancing Barrier Coating Solutions, with VerdaFresh, New Advanced Oxygen Barrier Technology

Dividend in the amount of 119.75615 agorot per share, record date: 8.6.26, payment 22.6.26

Shareholder Alert: Ademi LLP investigates whether Caesars Entertainment, Inc. is obtaining a Fair Price for Public Shareholders

Clinical trial NCT06170606: enrollment: not set → 200 participants.

Clinical trial NCT07221500: enrollment: not set → 100 participants.

Clinical trial NCT06123338: enrollment: not set → 49 participants.

Clinical trial NCT07232641 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-01 3. enrollment: not set → 185810 participants

Clinical trial NCT04919980: enrollment: not set → 65 participants.